On her way out the door when she quit working at Theranos Inc., Surekha Gangakhedkar says she printed and took company documents “to protect myself” -- because she suspected a pending launch of the company’s blood-testing machines in Walgreens stores would end badly.

The Covid-19 vaccine booster shot proposed by Pfizer Inc. and BioNTech SE should be given to older Americans and those at high risk, a panel of expert advisers to the U.S. Food and Drug Administration said, rejecting a request for broader distribution.

The 2022 Affordable Care Act marketplace enrollment period will increase from 45 to 75 days this year, and states will have the option to allow people with low incomes to sign up for coverage year-round, the Biden administration announced Friday.

Brazilian health regulator requested Janssen-Cilag to change its Covid-19 vaccine package in order to add adverse events identified during the monitoring of shot administration, the agency known as Anvisa says in a statement.

Drugmakers trying to show the FDA that their generic injectable products have a similar strength as existing products should demonstrate that both have an equivalent amount of drug substance in terms of content and concentration, the agency recommended in a draft guidance released Friday.

Exelixis has received U.S. FDA approval of Cabometyx in patients 12 years and older with previously treated radioactive iodine-refractory differentiated thyroid cancer.